Deferox 250 mg (Tablet)
Unit Price: ৳ 85.00 (3 x 10: ৳ 2,550.00)
Strip Price: ৳ 850.00
Medicine Details
Category | Details |
---|---|
Generic | Deferasirox |
Company | Beacon pharmaceuticals plc |
Also available as |
Indications
- Treatment of chronic iron overload due to repeated blood transfusions
- Indicated for thalassemia, sickle cell disease, myelodysplastic syndrome
- Treatment of chronic iron overload in non-transfusion-dependent thalassemia syndromes
Pharmacology
- Orally active chelator
- Highly selective for iron
- Binds iron in a 2:1 ratio
- Promotes excretion of iron in faeces
- Low affinity for zinc and copper
- Mean net excretion at different daily doses
Dosage
- Initial daily dose of 20-40 mg/kg body weight
- Administration on an empty stomach
- Dispersion in water or juice
- Monitoring of serum ferritin
- Dose adjustments based on trends in serum ferritin
Administration
- Taken once daily on an empty stomach
- Dispersed in water or juice
- No chewing of tablets
- Avoiding carbonated drinks or milk for dispersion
Interaction
- Avoidance with aluminium-containing antacids
- Caution with drugs metabolized through CYP3A4
- Potential dose increase with certain concomitant drugs
- Caution with drugs with ulcerogenic potential or anticoagulants
Contraindications
- Hypersensitivity to the active substance or excipients
- Creatinine clearance less than 40 ml/min
Side Effects
- Cytopenias
- Gastrointestinal effects
- Headache and dizziness
- Elevation of hepatic transaminases
- Rarely reported SJS and skin rash
- Auditory and ocular disturbances
Pregnancy & Lactation
- Pregnancy Category C
- Potential risk to the fetus
- Unknown excretion in human milk
Precautions & Warnings
- Gastrointestinal bleeding, ulceration, and irritation
- Cytopenias
- Hypersensitivity reactions
- Monitoring blood counts
- Caution in combination with drugs with known ulcerogenic or hemorrhagic potential
Use in Special Populations
- Similar safety and efficacy in pediatric patients
- Increased risk in elderly patients
- No studies in patients with renal or hepatic impairment
Overdose Effects
- Maximal dose information
- No information about overdose
Therapeutic Class
- Antidote preparations
Storage Conditions
- Store below 25°C
- Protect from light
- Keep out of the reach of children
Related Brands
- Asunra 100 mg (Dispersible Tablet) - novartis-bangladesh-ltd
- Asunra 400 mg (Dispersible Tablet) - novartis-bangladesh-ltd
- Ferasirrox 250 mg (Dispersible Tablet) - unimed-unihealth-pharmaceuticals-ltd
- Desirox 250 mg (Dispersible Tablet) - cipla-limited
- Desirox 500 mg (Dispersible Tablet) - cipla-limited